Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23842655.
- Also identified by DOI 10.1001/jamadermatol.2013.4957.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Several chemotherapeutic agents have been reported to induce subacute cutaneous lupus erythematosus (SCLE). To our knowledge, this is the first report to date of SCLE induced by monotherapeutic gemcitabine hydrochloride and includes a comprehensive review of all published cases of chemotherapeutic drug-induced SCLE. We describe a patient who developed a SCLE-like eruption after being administered gemcitabine and discuss 16 other published cases of chemotherapeutic drug-induced SCLE. This case and a review of the literature call attention to gemcitabine and other chemotherapeutic agents that have been reported to cause drug-induced SCLE. We also discuss the clinical features of the disease.
Medical subject headings
- Antimetabolites, Antineoplastic
- Deoxycytidine
- Drug Eruptions
- Lupus Erythematosus, Cutaneous